000 | 01133 a2200313 4500 | ||
---|---|---|---|
005 | 20250514075306.0 | ||
264 | 0 | _c20031107 | |
008 | 200311s 0 0 eng d | ||
022 | _a0014-2972 | ||
024 | 7 |
_a10.1046/j.1365-2362.2003.01224.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFödinger, M | |
245 | 0 | 0 |
_aLow clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing? _h[electronic resource] |
260 |
_bEuropean journal of clinical investigation _cSep 2003 |
||
300 |
_a737-9 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 |
_aHemochromatosis _xdiagnosis |
650 | 0 | 4 | _aHemochromatosis Protein |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xgenetics |
650 | 0 | 4 | _aHomozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPenetrance |
700 | 1 | _aSunder-Plassmann, G | |
773 | 0 |
_tEuropean journal of clinical investigation _gvol. 33 _gno. 9 _gp. 737-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2362.2003.01224.x _zAvailable from publisher's website |
999 |
_c12697041 _d12697041 |